pubmed-article:11884935 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0042172 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0206754 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0021212 | lld:lifeskim |
pubmed-article:11884935 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
pubmed-article:11884935 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11884935 | pubmed:dateCreated | 2002-3-8 | lld:pubmed |
pubmed-article:11884935 | pubmed:abstractText | Patients suffering from hepatic metastases of neuroendocrine tumors (NET) are potential candidates for orthotopic liver transplantation. Because recurrence rates are high and outcome is variable, prognostic indicators are required. The aim of our study was to identify predictors of long-term survival with a focus on the impact of tumor biology. | lld:pubmed |
pubmed-article:11884935 | pubmed:language | eng | lld:pubmed |
pubmed-article:11884935 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11884935 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11884935 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11884935 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11884935 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11884935 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11884935 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11884935 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:BoekerKlaus... | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:MannsMichael... | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:NashanBjörnB | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:KlempnauerJür... | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:SchmidtHartmu... | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:LangHaukeH | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:RosenauJensJ | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:BahrMatthias... | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:von... | lld:pubmed |
pubmed-article:11884935 | pubmed:author | pubmed-author:MengelMichael... | lld:pubmed |
pubmed-article:11884935 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11884935 | pubmed:day | 15 | lld:pubmed |
pubmed-article:11884935 | pubmed:volume | 73 | lld:pubmed |
pubmed-article:11884935 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11884935 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11884935 | pubmed:pagination | 386-94 | lld:pubmed |
pubmed-article:11884935 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:meshHeading | pubmed-meshheading:11884935... | lld:pubmed |
pubmed-article:11884935 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11884935 | pubmed:articleTitle | Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. | lld:pubmed |
pubmed-article:11884935 | pubmed:affiliation | Department of Gastroenterology and Hepatology, Medical School of Hannover, 30171 Hannover, Germany. | lld:pubmed |
pubmed-article:11884935 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884935 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884935 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884935 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884935 | lld:pubmed |